Lipid nanoparticles
AssigneeeTheRNA immunotherapies NV
InventorsStefaan DE KOKER, Sanne BEVERS, Peter TOMME
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of lipid nanoparticles more specifically comprising an ionisable lipid, a phospholipid, a sterol, a PEG lipid and one or more nucleic acids. The LNP's of the present invention are characterized in having a minimal average diameter of about 140 nm, thereby inducing a more potent immune response. The present invention provides use of the LNPs for immunogenic delivery of nucleic acid molecules, specifically mRNA; thereby making them highly suitable for use in vaccines, such as for the treatment of cancer or infectious diseases. Finally, methods are provided for preparing such LNP's.
Claims20
1-14. (canceled)
A lipid nanoparticle comprising:
- an ionizable lipid;
- from about 5 mol % to about 15 mol % of a phospholipid selected from the group consisting of DOPE, DOPC, and mixtures thereof;
- a sterol;
- a PEG lipid;
- and
- one or more nucleic acid molecules,
- wherein the lipid nanoparticle has a minimal average diameter of about 140 nm.
A method for the preparation of nucleic acid-containing lipid nanoparticles having a minimal average diameter of about 140 nm, the method comprising:
- preparing a first alcoholic composition comprising an ionizable lipid, a phospholipid, a sterol, a PEG lipid, and an alcoholic solvent;
- preparing a second aqueous composition comprising one or more nucleic acids and an aqueous solvent supplemented with a buffer;
- mixing the first alcoholic composition and the second aqueous composition in a microfluidic mixing device using the following settings:
- a Total Flow Rate (FR) from about 0.5 mL/min to about 8 mL/min;
- and
- a Flow Rate Ratio (FRR) from about 1/1 to 5/1.
Dependencies are inferred from the claim text.